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PEMBANGUNAN UJIAN-UJIAN DIAGNOSTIK BERDASARKAN DNA 
BAGI PENGESANAN Shigella dysenteriae, Shigella flexneri DAN 
 Shigella sonnei  
 
ABSTRAK 
 
Shigelosis atau disenteri basilus disebabkan oleh Shigella spp. merupakan masalah 
kesihatan yang signifikan di seluruh dunia. Cara pengenalpastian dan pengesanan 
patogen tersebut daripada tinja yang diamalkan kini iaitu dengan kaedah 
pengkulturan adalah sukar, memerlukan proses ujikaji yang cerewet, mempunyai 
kadar sensitiviti yang rendah dan mengambil masa yang lama (2 hingga 5 hari) untuk 
mendapat keputusan. Dalam kajian ini, ujian tindakbalas rantai polimerase dengan 
reagen yang dihasilkan secara beku-kering atau stabil terma telah dicipta untuk 
pengesanan gen ompA pada Shigella dysenteriae, Shigella flexneri dan Shigella 
sonnei. Ujian-ujian yang dicipta mengandungi primer spesifik, reagen beku-kering 
tindakbalas rantai polimerase dengan kawalan dalaman (IC) dan pewarna muat turun 
jeli.  
 
Optimasi parameter tindakbalas rantai polimerase dilakukan meliputi suhu pelekatan 
(Ta°C) dan kepekatan MgCl2. Ujikaji kepekaan dan kespesifikan dijalankan dengan 
menggunakan kultur tulen S. dysenteriae, S. flexneri, S. sonnei dan bakteria enterik 
lain. Hasil ujikaji menunjukkan tiada tindakbalas dihasilkan daripada templat DNA 
bukan sasaran. Lima pg/µl DNA IC dimasukkan ke dalam ujian selepas ujikaji 
optimasi kepekatan templat DNA IC dilakukan. Amaun minima templat DNA 
genomik yang dapat dikesan oleh ujian-ujian yang dicipta adalah 0.39 ng/µl untuk S. 
 xv 
sonnei dan S. flexneri manakala 0.78 ng/µl untuk S. dysenteriae. Analisis kepekaan 
bilangan bakteria (cfu) pula mendapati kepekaan adalah 4.0 x 10
3
 cfu setiap reaksi 
tindakbalas rantai polimerase untuk ujian S. dysenteriae manakala bagi S. flexneri 
dan S. sonnei pula adalah 4.0 x 10
4 
cfu. Analisis kestabilan reagen stabil terma 
tindakbalas rantai polimerase yang dijalankan dengan menyimpan reagen berkenaan 
pada suhu bilik (25-26 °C)  dan pada 4 °C mendapati reagen stabil disimpan sehingga 
6 bulan. Ujikaji tempoh pengeraman optimum kultur tinja di dalam GNB yang 
dijalankan mencadangkan pengeraman perlu dilakukan selama 8 hingga 12 jam 
sebelum ujian tindakbalas rantai polimerase dibuat. 
 
Kajian penilaian awal atau evaluasi awal di dalam makmal menggunakan tinja 
kanak-kanak yang dimasukkan kultur tulen S. dysenteriae, S. flexneri, S. sonnei dan 
bakteria enterik telah dilakukan (n=50). Berdasarkan keputusan ujikaji, didapati ujian 
yang dibangunkan untuk S. dysenteriae dan S. sonnei adalah 100% untuk spesifisiti 
dan sensitiviti, begitu juga dari segi NPV (Nilai Jangkaan Negatif) serta PPV (Nilai 
Jangkaan Positif) iaitu 100% . Manakala bagi asai yang dibangunkan untuk  S. 
flexneri pula, sensitiviti adalah 100%, spesifisiti 92.8%  dengan PPV 92.8% dan NPV 
100% . Kajian ini telah berjaya menghasilkan ujian yang ringkas, pantas, sensitif, 
spesifik dan berkos rendah dengan kawalan dalaman bagi pengesanan S. dysenteriae, 
S. flexneri, dan S. sonnei. Namun begitu, kajian lanjutan menggunakan bilangan 
sampel tinja lebih banyak dan tinja orang dewasa perlu dilakukan untuk menilai 
potensi sebenar asai yang dicipta. 
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DEVELOPMENT OF DNA-BASED DIAGNOSTIC TESTS FOR THE 
DETECTION OF Shigella dysenteriae, Shigella flexneri AND Shigella sonnei 
 
ABSTRACT 
 
Shigellosis or bacillary dysentery caused by Shigella spp. remains as significant 
health problem worldwide. Current detection and identification methods of the 
pathogens from stool specimens by culture method is relatively insensitive, generally 
time consuming (~ 2-5 days) and laborious. In this study, thermostabilised 
Polymerase Chain Reaction (PCR) assays were developed for the detection of ompA 
genes in Shigella dysenteriae, Shigella flexneri and Shigella sonnei. The tests 
contained specific primers for the detection of S. dysenteriae, S. flexneri and S. 
sonnei respectively, freezed-dried or thermostabilised PCR reagents with Internal 
Control (IC) and gel loading dye.  
 
Optimization of PCR parameters including annealing temperature (Ta °C) and MgCl2 
concentrations was performed. In assessing specificity and sensitivity, the primers 
were challenged with known S. dysenteriae, S. flexneri, S. sonnei and other enteric 
pathogens. None of the DNA template from non-targeted organisms was amplified. 
Five pg/µl of IC was incorporated into the assays after optimization of IC DNA 
template concentration was done. Minimum concentration of genomic DNA that 
could be detected by the assays was 0.39 ng/µl for S. sonnei and and S. flexneri .As 
for the detection of S. dysenteriae was 0.78 ng/µl. At bacterial level, the sensitivity 
was found to be 4.0 x10
3
 cfu/PCR reaction for the test developed for the detection of 
S. dysenteriae and 4.0 x10
4 
cfu/PCR reaction
 
for S. flexneri and S. sonnei. 
 xvii 
Thermostabilised PCR mix periodic stability assessment for each test was done at 
ambient temperature (25-26°C) and 4°C. Results suggested that the reagent is stable 
until 6 months of storage at both temperatures. Optimization of stool culture in GNB 
(Gram Negative broth) was done in order to measure optimum incubation time prior 
to PCR assay. The optimum time was found to be 8 to 12 hours for all tests. 
 
Preliminary evaluation of the developed tests was done using children seeded stool 
culture in GNB with S. dysenteriae, S. flexneri, S. sonnei and other enteric bacteria 
(n=50). The PCR results gave 100% for sensitivity and specificity, with 100% 
Positive Predictive Value (PPV) and Negative Predictive Value (NPV) for the test 
developed for the detection of S. dysenteriae and S. sonnei. As for the detection of S. 
flexneri, the sensitivity was found to be 100% and for specificity, 92.8%. Therefore, 
the PPV and NPV was 92.8% and 100% respectively. This study has developed 
simple, rapid, sensitive, specific and cost-effective tests with built-in control for the 
detection of S. dysenteriae, S. flexneri, and S. sonnei. However, further studies with a 
larger set of sample probably using adult stool need to be done to evaluate the true 
performance of the developed tests. 
 
 
 1 
CHAPTER 1 
 
 INTRODUCTION 
 
1.1 Introduction to Shigella 
1.1.1 History and discovery of Shigella 
Shigella is the primary causative agent of bacillary dysentery or shigellosis  
characterized by bloody stools containing mucus (Navia et al., 2005). Isolation of 
this bacterium from faeces of individuals with acute dysentery was first described 
by Chantamesse and Widel in 1888 (Lan and Reeves, 2002). Later, Kiyoshi Shiga, a 
Japanese bacteriologist reported detailed description of the organism that caused the 
dysentery in 1898 (Hale, 1998; Niyogi, 2005). Shigella dysenteriae type 1, initially 
termed Bacillus dysenteriae, was the first Shigella spp. isolated by Shiga. Forty 
years after the discovery, three additional groups of related organisms were defined 
and taxonomically placed in the genus Shigella. They were named Shigella flexneri, 
Shigella boydii and Shigella sonnei in honor to the investigators Flexner, Boyd and 
Sonne. The 1950 Congress of the International Association of Microbiologists 
Shigella Commission adopted the generic name of Shigella, in honor of Shiga 
(Hale, 1998). Species subgroups A (S. dysenteriae), B (S. flexneri), C (S. boydii) 
and D (S. sonnei) were also designated by the commission. All of the Shigella 
species were found to be pathogens to human (Coimbra et al., 2001). 
 
In the earlier classification, Escherichia coli and Shigella were classified in the same 
genus because of their genetic similarity. Escherichia coli and Shigella spp. cannot 
be differentiated on the polynucleotide level in some reported DNA hybridization 
studies. They share greater than 90% homology by DNA-DNA reassociation analysis  
(Boileau et al., 1984; Wang et al., 1997; Faruque et al., 2002; Lan et al. 2004). 
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However, recently comparative genomic studies between the two organisms revealed 
that 175 of the total 3235 open reading frames were exclusively for S. flexneri  (Wei 
et al., 2003; Lan et al., 2004). Shigella spp. were allocated in a different genus from 
E. coli because of their medical significance, human host interactions, pathogenicity, 
physiology and serological characteristics (Escobar-Paramo et al., 2003). Shigella 
spp. are non-motile, lactose negative. They ferment glucose and other carbohydrates 
without producing gas. These characteristics differentiate Shigella from typical 
Escherichia coli which are positive for those characteristics. The ability to cause 
acute bacillary dysentery to human by invading the colonic mucosa cells and produce 
tissue damage differentiated Shigella spp. from certain strains of E. coli (Brenner et 
al., 1982). 
 
1.1.2 Shigellosis epidemiology 
Shigellosis has been reported to be a global human health problem. The annual 
global burden of shigellosis episodes throughout the world was estimated to be 164.7 
million; 163.2 million cases (1.1 million deaths) were in developing countries and 
1.5 million in industrialized countries (Kotloff et al., 1999; Niyogi, 2005). The 
reported mortality rate was approximately 0.7%. In Asia, the burden was estimated 
from published studies initiated in Asia countries after the year 1990. The annual 
episodes and deaths were estimated to be 91 million and 414 000 respectively with S. 
flexneri as the commonest serotype followed by S. sonnei (Kotloff et al., 1999; 
WHO, 2005). Majority of Shigella infections are due to endemic shigellosis 
especially in numerous developing countries. Studies carried out in developing 
countries had reported that Shigella is associated with 5% to 15% of the diarrheal 
cases and 30% to 50% of dysentery cases (Faruque et al., 2002; Hiranrattana et al., ; 
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2005). It is responsible for approximately 10% of all diarrheal episodes among 
children age below five years living in developing countries and up to 75% of 
diarrheal deaths (Kotloff et al., 1999; Niyogi, 2005). 
 
Worldwide, the four species of Shigella; S. dysenteriae, S. flexneri, S. boydii and S. 
sonnei have been reported to be responsible for mortality and morbidity for bloody 
diarrhea especially in developing countries with substandard hygiene and poor 
quality of water supplies (CDC, 2005; Niyogi, 2005). In the United States and 
Europe, Shigella spp. continue to be responsible for morbidity and mortality in high 
risk population in association with over crowding and poor personal hygiene such as 
senior citizens, people in prisons and crowded refugee camps, patients in mental 
hospitals, toddlers in day-care centres and among homosexual men (Niyogi, 2005).  
 
The geographical distribution of the four serogroups of Shigella is varying, as is their 
pathogenicity (Opintan and Mercy, 2007). The predominant serogroups of Shigella 
circulating in a community appear to be related to the level of socioeconomic 
development. Epidemic and endemic disease being caused by S. dysenteriae type 1 
occur worldwide. In most developed countries or industrialized nations, infections by 
Shigella are usually due to Shigella sonnei .(WHO, 2009). In United States, most of 
shigellosis outbreaks were due to S. sonnei. Meanwhile, S. flexneri remains the 
leading species that cause shigellosis in most of developing countries and resource-
poor countries. In Singapore, a study conducted by Lim and Tay (1991) had reported 
that S. flexneri was the most frequent isolated strains (60.3%) followed by S. sonnei 
(33.6%), S. boydii (3.2%) and S. dysenteriae (3%) among total isolated Shigella 
(506) in four years, from 1986 to 1990. Studies done in  five resource poor countries; 
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Bangladesh, China, Pakistan, Indonesia and Vietnam  found that S. flexneri was the 
most frequently isolated species whereas in Thailand, which is rapidly becoming 
industrialized S. sonnei was found to be the most common species (Lorenz Von S. et 
al., 2006). The fourth species, S. boydii was first found in India and uncommonly 
encountered except in the Indian subcontinent. The median percentage of isolates of 
S. flexneri, S. sonnei, S. boydii and S. dysenteriae in developing countries were 60%, 
15%, 6% and 6% respectively while in developed countries were 16%, 77%, 2% and 
1% respectively (Kotloff et al., 1999). In Iran, a study conducted involving Iranian 
children less than 5 years old with acute diarrhea showed that out of 555 faecal 
samples, Shigella spp. (26.7%) was the most prevalent bacterial pathogen isolated 
(Jafari et al., 2009). 
 
In Indonesia, Shigella spp. was reported to be  the most frequently isolated pathogen 
associated with diarrhea; led by S. flexneri, followed by S sonnei and S. dysenteriae 
(Buhari et al., 2002). A case-control study to characterize the epidemiology of 
bloody diarrhea in rural Western Kenya had reported that 80% of the bacterial 
pathogens isolated were due to Shigella spp and 49% was caused by S. flexneri 
(Brooks et al., 2003). Generally, the incidence and fatality rates due to shigellosis are 
highest among very young children and the elderly. The highest incidence of 
shigellosis is in young children especially under 5 years of age (Kotloff et al., 1999; 
Lorenz von S. et al., 2006). A study conducted in Pakistan had reported that Shigella 
spp. were commonly isolated among children having diarrhea. S. flexneri was 
identified as the most frequently isolated species compared to S. dysenteriae, S. 
boydii and S. sonnei (Kausar et al., 1998).  
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In Malaysia, there are lack of reports on the prevalence of shigellosis. In a study done 
by Lee and Puthucheary (2002) on bacterial Enteropathogens in childhood diarrhea 
in urban hospitals, Shigella spp. was the third most common bacteria isolated from 
stool samples. This retrospective study was conducted among children admitted due 
to diarrhea at the University of Malaya Medical Centre (UMMC), Kuala Lumpur, 
from year 1978 to 1997. Shigella spp. was isolated from 1.4% (386 isolates) of the 
total stool specimens, which corresponded to 13% of the 2986 isolates found positive 
for bacterial pathogens. S. flexneri was found to be the most frequently isolated 
species reported of all Shigella isolates from 1970s to early 1990s, followed by S. 
sonnei (Lee and Puthucheary, 2002). However, from 1993 to 1997, the number of S. 
sonnei strains isolated surpassed S. flexneri. A year after that, another retrospective 
analysis was conducted among children admitted with diarrhea but this time to 
Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia. The study showed 
that the isolation rate of S. flexneri was 2.28% out of 1097 stool specimens studied 
(Ludin et al., 2003).  
 
1.1.3 Shigella classification 
Shigella belongs to the tribe Escherichia in the family of Enterobacteriaceae. The 
genus of Shigella was classified into four species based on biochemical basis and 
serological differences; S. dysenteriae, S. flexneri, S. boydii and S. sonnei. S. 
dysenteriae consist of 13 serotypes, S. flexneri consist of 8 serotypes, S. boydii 
consist of 18 serotypes and S. sonnei consist of 1 serotype. Serotyping was based on 
the presence of O antigen component of lipopolysaccharide on the outer membrane 
of the cell wall.   
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1.1.4   Shigella properties 
1.1.4.1    Physical characteristics 
Shigella is a gram negative small rod bacteria which is non-capsulated with a size 0.3 
to 1 µm in diameter with length 1 to 6 µm. It has no flagella and non-motile (no H 
antigens). This bacteria posses K and O antigens. The O antigen is useful in 
serological identification to classify the four species. The K antigen is the capsule 
antigen which occasionally inteferes with the determination of O antigen. Shigella 
strains produce 3 distinct enterotoxins. SHET 1 a chromosome encoded Shigella 
enterotoxin 1 present in all S. flexneri 2a but rarely found in other Shigella serotypes. 
SHET2, Shigella enterotoxin 2 located on a large plasmid associated with virulence 
of Shigella. The enterotoxin produced by S. dysenteriae only is called Shiga toxin or 
verotoxin. The toxin is neurotoxic, cytotoxic and enterotoxic encoded by 
chromosomal genes with 2 domains, 1-A (32 kDa) and 5-B (7.7 kDa). 
 
1.1.4.2   Growth and culture characteristics 
Shigella is a facultative anaerobe. This bacterium is able to grow at temperatures 
ranging from 12°C to 48°C with an optimum growth temperature at 37°C and at a pH 
range of 5.0 to 7.3. Shigella spp. are acid resistant and can pass the gastric acid 
barrier but are sensitive to the increment of temperature, decrement of pH and 
increment of NaCl concentrations that will lead to their deaths. A number of 
commercially prepared plating media are appropriate for culturing Shigella. 
MacConkey (MAC), Xylose Lysine Desoxycholate (XLD), Hektoen (HEK), 
Salmonella-Shigella (SS) and Desoxycholate Citrate Agar (DCA) are among the 
common selective or differential agar media used for the recovery of Shigella 
(Clemens et al., 1999). However, S. dysenteriae type 1 and S. sonnei do not grow 
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well on Salmonella-Shigella agar. Shigella spp. has typical non-lactose fermenting 
characteristic colonies on lactose enriched media such as on MAC, DCA and SS 
agar. Colonies on MAC and DCA agar appears to be 2 to 3 mm in diameter, 
translucent and colorless or non-lactose fermenting. On XLD agar, the colonies 
appear to be much smaller; 1 to 2 mm in diameter and red in colour as lysine is 
decarboxylated to produce alkaline end products which raised the pH and change the 
agar into deep red colour. On the HEK agar, the colonies appear to be blue-greenish 
in colour.  
 
 1.1.4.3   Biochemical characteristics 
All Shigella spp. do not produce hydrogen sulphide (H2S) on the XLD, HEK and SS 
agar. All serotypes do not ferment lactose but cultures of S. sonnei utilize this 
substrate after prolonged incubation (more than 24 hours incubation). Shigella 
utilizes glucose and other carbohydrates, producing acid with no gas except for 
certain biotypes of S. flexneri and is oxidase negative. Indole is not produced and 
methyl red (MR) test is positive. Shigella is negative for lysine decarboxylase. Most 
isolates of S. sonnei are able to produce ornithine decarboxylase. Rare isolates of S. 
boydii are ornithine positive. Other serotypes are not able to produce ornithine 
decarboxylase. Serogroups A, B and C are similar biochemically except for S. 
sonnei. Positive beta-D-galactosidase and ornithine decarboxylase biochemical 
reactions differentiated S. sonnei from other serotypes (Cheesbrough, 1984; Clemens 
et al., 1999). 
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1.2  Shigellosis by Shigella spp. 
1.2.1  Reservoirs and modes of transmission 
Natural hosts for Shigella are humans and primates. The predominant mode of 
transmission is by faecal-oral route where personal hygiene is poor. The infective 
dose is very low, varying from 10 to 10
3 
organisms renders shigellosis a highly 
contagious disease (Du Pont et al., 1989; Villabo and Torres, 1998; Navia et al., 
2005). The infective dose is lower than other enteric pathogens such as Vibrio spp., 
Salmonella spp. and Campylobacter spp. which require at least 10
4 
to 10
5 
organisms 
to cause infection. Persons symptomatic with diarrhea were reported to be primarily 
responsible for the transmission (García-Fulgueiras et al., 2001). The disease is 
usually acquired by consumption of contaminated water and food but sometimes 
through contact with contaminated inanimate object and sexual contact; mainly 
among men who have sex with men (Lampel et al., 1990; Villabo and Torres, 1998; 
Lindqvist, 1999; Hamamoto et al., 2000; Niyogi, 2005). Consumption of raw or 
uncooked vegetables where sewage was used as fertilizer (Sur et al., 2004) and 
eating of cheese and oysters that has been contaminated by infected food handlers 
has been reported to be the cause of shigellosis (García-Fulgueiras et al., 2001; Jun et 
al., 2004).   
 
Transmission may also occur through contaminated fomites. In areas where disposal 
of human faeces is inappropriate, flies, specifically Musca domestica, may serve as 
vectors for the transmission of shigellosis (Sur et al., 2004; Niyogi, 2005). Infected 
people may excrete Shigella in large numbers in the stools, up to 10
5
-10
9
 bacteria per 
gram stool (Kausar et al., 1998; Ahmed et al., 2003). The organism can be found in 
the faeces for weeks after symptoms have ceased. It has been reported that this 
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organism is able to survive in soiled linen for up to seven weeks, in salt water for 12 
to 30 hours, in dust for 6 weeks at room temperature, in refrigerator for at least 1 
week , in fresh water for 5 to 11 days, in sour milk for 4 weeks and in kitchen refuse 
for 1 to 4 days (Lampel et al., 1990; Sur et al., 2004).  
 
1.2.2 Incubation period 
Shigellosis typically evolves through several phases. Manifestations of Shigella 
infection vary with the infecting species, the presence of risk factors, the age of the 
host and the specific immune status of the host. The incubation period is typically 1 
to 4 days and sometimes may be as long as 8 days with S. dysenteriae infection. 
Severe cases require immediate appropriate medication. In mild cases, the disease 
sometimes may be self limiting which will resolve within 5 to 7 days without 
sequelae (Hale, 1991; Hale, 1998). 
 
1.2.3 Pathogenesis 
The fundamental event in the pathogenesis of Shigella is the ability to invade and 
colonize the human intestinal epithelium. The disease is characterized by the 
destruction of the colonic epithelium provoked by the inflammatory response that is 
induced upon invasion of the mucosa by Shigella (Parsot, 2005). Infection is 
generally localized or limited to the intestinal mucosa areas. After oral inoculation, 
Shigella passes the terminal ileum and colon where it invades and proliferates within 
epithelial cells and spread cell to cell. Those abilities are the key determinants of the 
disease that elucidated acute inflammatory reaction (Islam et al., 1997; Alfredo, 
2004).  
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The organism can enter both erythrocytes and M cells, which are special epithelial 
cells overlying mucosal lymphoid follicles. The infection process involves multiple 
steps including macropinocytosis, escape into the cytosol followed by multiplication 
and passage to the adjacent cells. Shigella uses the type III secretion system to invade 
the epithelium cells and involves approximately 20 proteins which are encoded by 
the 210 kb virulent plasmid. Among the proteins secreted are VirA, OpsB to OpsG 
and invasion plasmid antigens (Ipa) proteins such as IpaB, IpaC, IpaD and IpaH. 
Most of the virulence determinants responsible for invasion of epithelial cells are 
encoded by a 213 kilobase (kb) plasmid that is unique to virulent Shigella and 
enteroinvasive E. coli (EIEC) strains. Pathogenic mechanism of shigellosis has been 
extensively studied and published (Hale, 1991; Tran Van Nhieu and Sansonetti, 
1999; Sansonetti, 2001; Fernandez and Sansonetti, 2003).  
 
In endemic areas, the incidence of shigellosis peaks during the first 5 years of life 
and declines thereafter, suggesting that immunity develops after repeated exposures 
during childhood (Taylor et al. 1986; Ferrerico et al., 1991). Antibody responses to 
the somatic antigens of Shigella develop early in infection and follow the typical 
course for anti-LPS antibodies, which is IgM response that peaks within weeks and 
wanes after 1-2 years (Sur et al., 2004). Serotype specific natural immunity was 
reported by a longitudinal study of a cohort of Chilean children in whom primary 
Shigella infection conferred 76% protective efficacy against reinfection with the 
same serotype (Cohen et al., 1992). Adult volunteers who were experimentally 
infected with either S. sonnei or S. flexneri were found to be significantly protected 
against shigellosis following rechallenge with the homologous strains (Herrington et 
al., 1990; Kotloff et al., 1995). 
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1.2.4 Clinical manifestation 
There are several phases in shigellosis. The incubation period is 1 to 4 days after oral 
inoculation but in certain cases may be as long as 8 days with S. dysenteriae (Sur et 
al., 2004). Clinical disease typically begins within 24-48 hours of ingestion of a few 
hundred to a few thousand organisms (Hale, 1998). Among the first symptoms to 
occur are fever with other constitutional symptoms such as malaise, fatigue, stomach 
cramps, headache, anorexia and occasional vomiting. These will be associated with 
frequent passage of small stool volume that consist of blood, mucus and pus. Patients 
with severe infection may pass more than 20 dysenteric stools in a day. Blood, 
mucus and pus cells found in the stools suggest colorectal inflammation due to the 
infection (Li, 2000). Infections by Entamoeba histolytica, Campylobacter spp. and 
Salmonella spp. also manifest similar symptoms but usually generate self-limited 
illness that is rarely as serious as shigellosis. There were some cases that shigellosis 
cannot be distinguished clinically from diarrhea caused by other enteric pathogens. 
This is due to acute non-bloody diarrhea that may be caused by certain strains of 
Shigella. Clinical symptoms usually persist for 10 to 14 days and sometimes longer 
(Alfredo, 2004). 
 
In some severe shigellosis cases, the infection may become life threatening and 
contribute to substantial mortality especially among young children. A study 
conducted by Khan and colleagues had reported that severe infections of shigellosis 
may cause high grade fever associated with seizures among children 5 years of age 
or less (Khan et al., 1999). Studies on the effects of diarrhea on the growth of 
children living in developing countries had suggested that dysentery caused by 
Shigella spp. is associated with significant growth retardation (Alam et al., 2000). 
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Daily loss of 200-300 ml of serum protein into the faeces during the infection 
exacerbates malnutrition and growth stunting. The loss of serum proteins results in 
depletion of nitrogen stores (Alam et al., 2000). Decreament of immune system also 
increases the risk of shigellosis and contributes to substantial mortality.  
 
1.2.5 Complications 
Complications due to shigellosis are rare but may happen in severe cases. Shigellosis 
may be associated with a large number of mild to severe life-threatening 
complications, particularly due to S. dysenteriae type 1. Most episodes of shigellosis 
in healthy individuals are self-limited and resolve within 5 to 7 days without sequlae. 
Persistent diarrhea and malnutrition are the most common chronic sequlae (Niyogi, 
2005).  
 
Life threatening complications are most often seen in malnourished infants and 
young children living in developing countries. These include metabolic 
derangements; dehydration, hyponatraemia and hypoglycaemia, intestinal 
complications; toxic megacolon, rectal prolapse, intestinal perforation and rarely 
sepsis. HIV-associated immunodeficiency and immunocompromised patients have 
been reported to have severe shigellosis, including persistent or recurrent intestinal 
disease and bacteremia (Kristjansson et al., 1994; Angulo and Swerdlow, 1995). 
Reactive inflammatory arthritis (Hannu et al., 2005), conjunctivitis, urethritis known 
as Reiter‟s syndrome and anorexia also has been reported as complications due to 
severe shigellosis. Microangiopathic haemolytic anaemia can complicate infection 
with Shiga toxin-producing organisms, manifesting as the haemolytic uraemic 
syndrome (HUS) in children and as thrombocytopenic purpura in adults (Niyogi, 
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2005). Shigellosis was also reported to cause acute appendicitis in children (Tayman, 
2008) and associated to chronic vulvovaginitis in children (Namdari et al., 2002). 
 
1.2.6 Management (treatment and prevention) 
In order to treat shigellosis patients, rehydration treatment developed by the World 
Health Organization (WHO) has proven to be effective and is the treatment of choice 
for acute diarrhea. In acute dehydration, oral rehydration salt (ORS) is recommended 
while in severe dehydration, intravenous fluids usually Ringer‟s lactate solution is 
recommended (Sur et al., 2004; Niyogi, 2005).  
 
In the management of shigellosis, antibiotics treatment also plays an important role. 
Use of appropriate antibiotic hastens recovery from shigellosis, shorten the duration 
of excretion of Shigella, decrease spreading of the pathogen and possibly prevent 
complications. Treatment in malnourished children especially in developing 
countries will reduce the risk of worsening malnutrition morbidity due to shigellosis 
(Alam et al., 2000; Ashraful et al., 2005). A variety of antibacterial agents are 
effective for treatment of shigellosis. Commonly prescribed antibiotics in treating 
shigellosis are ampicillin, tetracycline, amoxicillin, cotrimoxazole, chloramphenicol 
and trimethoprim-sulfamethoxazole. Nevertheless, options are becoming limited due 
to globally emerging drug resistance (Vrints et al., 2009). Shigella resistance to 
sulfonamides, tetracyclines, ampicillin and trimethoprim-sulfamethoxazole has been 
reported worldwide (Lima et al., 1995; Replogle et al., 2000; Pickering, 2004; Temu 
et al., 2007; Sire et al., 2008). Studies in Asian regions such as Thailand, Vietnam 
(Isenbarger et al., 2002),  Singapore (Lim and Tay, 1991), Indonesia (Tjaniadi et al., 
2003) and Malaysia (Jegathesan, 1984; Thong et al., 2002; Lee and Puthucheary, 
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2003) also have reported the emergence of multi-resistant strains of Shigella.  The 
Shigella resistance locus (SRL), have been identified in Shigella strains which 
mediates resistance to antibiotics (Turner et al., 2003). In Malaysia, out of 100 
clinical strains of Shigella tested, 73% were resistant to at least one antibiotic (Thong 
et al., 2002). Another study done had reported that out of 241 isolates of Shigella 
tested, 58% were resistant to at least one antibiotic and the rest were multi-resistant 
to three or more antibiotics (Lee and Puthucheary, 2003). Antimicrobial 
susceptibility and pulsed-field gel electrophoresis study done by Thong and 
colleagues on 62 Shigella sonnei strains isolated in Malaysia from year 1997 to 2000 
revealed that multi-drug-resistant strains were circulated in different parts of 
Malaysia.  
As in the case of other enteric infections, the spread of Shigella from an infected 
person to other persons can be stopped by increasing personal hygiene. Appropriate 
hand washing with soap, safe disposal of human waste as well as safe food 
processing and handling are the basis of personal hygiene that will contribute to 
minimize the transmission of Shigella. A study carried out in Bangladesh had 
reported that good personal hygiene practice greatly reduced the incidence of 
shigellosis (Khan, 1982).  
 
1.3 Shigellosis diagnosis 
1.3.1 Clinical diagnosis 
The diarrhoeal stage of the infection cannot be distinguished clinically from the other 
bacterial, protozoan and viral infections. Therefore clinical diagnosis of shigellosis is 
not specific. Bloody, mucoid stools are highly indicative of shigellosis (WHO, 2009). 
The presence of fever suggests an infection by invasive pathogen. Patients presenting 
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with watery diarrhoea and fever should be suspected of having shigellosis, but the 
differential diagnosis should include infection caused by enteroinvasive Escherichia 
coli (EIEC), Salmonella enteritidis, Yersinia enterolitica, Campylobacter spp. and 
Entamoeba hystilotica (Ashraful et al., 2005; Niyogi, 2005). Usually, fresh and 
bright red blood is present in the patients with shigellosis rather than dark brown in 
stools of patients with amoebiasis (Niyogi, 2005).  
 
1.3.2 Laboratory diagnosis   
1.3.2.1    Bacteriology 
1.3.2.1.1 Stool examination 
In order to diagnose the dysentery, macroscopic and microscopic examinations have 
to be done to the faeces of the suspected patients. Faecal specimens from patients 
with shigellosis may be watery, contain blood and mucus in the early stage of 
infection. In the later stages of infection, pus and blood mixed with mucus can be 
seen in almost entirely of specimens. In macroscopic examination, characteristics of 
faeces are examined which include consistency (formed stool, liquid stool or 
semisolid) and presence of atypical components (such as mucus and blood). As for 
microscopic examination, presence of hemoglobin and leukocytes are examined from 
fresh and unstained suspension of faeces (Cheesbrough, 1984). Invasion of the 
intestinal wall and the consequent inflammatory reaction resulted in the infiltration of 
the polymorphonuclear leukocyte and hemoglobin in the faecal secretion. It has been 
reported that faecal blood or leukocytes are detectable in the faeces in approximately 
70% of shigellosis cases, whereas both faecal blood and leukocytes are detected in 
approximately 50% of the cases (Echeverria et al., 1991).  
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1.3.2.1.2   Stool culture 
Although clinical signs may evoke the suspicion of shigellosis, diagnosis is 
dependent upon the isolation and identification of Shigella from the stool specimen. 
The isolation usually done by conventional culture methods followed by 
identification by biochemical tests and serological agglutination assays (WHO, 
1987). Culture is required for antibiotic susceptibility testing. Specimens are 
collected in the early stage of the disease, preferably before antibiotic treatment is 
begun. During that stage, the pathogens usually present in high number in the stool 
therefore chances of recovering the organisms are higher (Niyogi, 2005). Shigella 
spp. is fastidious and survive poorly in stool samples with mixed flora at room 
temperature (Taylor and Schelhart, 1975). Ideally, stool samples should be processed 
immediately, within 2 to 4 hours after collection. Specimens that cannot be processed 
within the optimum time should be stored at 4°C in appropriate transport media such 
as buffered glycerol saline or Cary-Blair medium. Appropriate specimens collection, 
rapid transport to the laboratory and rapid processing of the sample with ideal media 
used for isolation are important criteria for successful recovery of Shigella (Clemens 
et al., 1999; Sur et al., 2004). Those criteria are usually difficult to be attained 
resulting shigellosis undiagnosed (Dutta et al., 2001).  
 
1.3.2.1.2 (a)   Inoculation on selective differential media 
Isolation of Shigella typically involves an initial streaking on differential or selective 
media with aerobic incubation to inhibit the growth of the anaerobic normal flora. 
Primary isolation media that commonly being used are MacConkey (MAC), Xylose 
Lysine Desoxycholate (XLD), Desoxycholate Citrate (DCA), Hektoen Enteric 
(HEK) and Salmonlla-Shigella (SS) agar as mentioned in section 1.1.4.2. These 
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selective media contain bile salts that will inhibit the growth of other Gram-negative 
bacteria and have pH indicators to differentiate lactose fermenters organisms 
(coliforms) from non-lactose fermenters (Shigella). Inoculation of stool specimens 
into liquid enrichment broth such as Hajna Gram-negative broth or Selenite F broth 
may enhance the viability of the organisms before subculturing onto the selective 
media (Clemens et al., 1999; Theron et al., 2001). Inoculation on selective agar 
media is done by dropping a single drop of liquid faecal suspension or by streaking 
directly using rectal swab or faeces swab. The inoculated agar media should be 
incubated at 37°C for 18 to 24 hours. Characteristics of Shigella colonies on those 
selective agar media are as mentioned in section 1.1.4.2. Suspected colonies were 
chosen and further identified using biochemical and serological tests.  
 
1.3.2.1.2 (b)   Biochemical screening tests 
Biochemical tests are used for further identification of Shigella spp. These tests are 
performed by inoculating the suspected colonies into different biochemical screening 
media. The media used are Kigler iron agar (KIA) or triple sugar iron agar (TSI), 
motility medium, MR (Methyl Red) -VP (Voges-Proskauer) test medium, oxidase 
test medium, citrate agar and urea agar (WHO, 1987). The Shigella spp. is usually 
positive for MR test and negative for citrate, oxidase, urease, motility and VP test. 
Growth of Shigella on TSI agar produces alkaline slant and acid butt due to ability to 
ferment lactose aerobically in the slope and the anaerobic fermentation of glucose in 
butt, with no production of gas and H2S. However, a few strains of S. flexneri 
serotype 6 and very rare strains of S. boydii produce gas in KIA or TSI (Clemens et 
al., 1999).  
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1.3.2.1.2 (c)   Serological identification 
Serological identification is performed to confirm the isolation and further species 
classification of the Shigella isolates (WHO, 1987). Each species of Shigella owns a 
distinctive type of O antigen. The identification is done by performing slide 
agglutination test using commercially available polyvalent O antigen grouping sera. 
In some cases, specific serotype identification can be done by using monovalent 
antisera for serotypes and sub-types identification. The test is carried out by 
emulsifying the colonies from the surface of KIA or TSI or other non selective agar 
media in a drop of physiological saline on a clean glass slide. Colonies from selective 
agar media such as MAC are not advisable because it may produce false-negative 
results. A small drop of polyvalent or monovalent antisera is mixed with the colonies 
suspension to observe for agglutination reaction. Shigella polyvalent antisera will 
agglutinate strains of the same serogroups and monovalent antisera will agglutinate 
the specific serotype or subtype. Cultures that react serologically (agglutinates) and 
show strong suggestive results in the biochemical screening tests are reported as 
positive for Shigella (Cheesbrough, 1984). 
 
1.3.3 Other Diagnostic techniques 
1.3.3.1 Immunological assay 
Immunological assays have been used for the detection of specific identification of 
bacterial infections in most laboratories. The antibody based assays comprise the 
largest group of rapid methods being used in bacterial identification. Several basic 
formats of antibody-based assays are latex agglutination, immunodiffusion and 
enzyme immunoassays (EIA). EIA is the most common format since it can be used 
for testing large numbers samples and it is suitable for automation and quantification.  
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There are many different EIA methods developed for the diagnosis of shigellosis. A 
study done in Kuwait has developed a monoclonal antibody-based enzyme-linked 
Immunosorbent assay (ELISA) using a 43 kDa invasion plasmid-coded protein 
antigen (IpaC) to identify EIEC and Shigella strains  in faecal samples from children 
(Pal et al., 1997). Another ELISA method was developed using purified recombinant 
IpaD (Oaks et al., 1996). ELISA technique has also been used for the detection of 
serum and urine antibodies of various immunoglobulin against Shigella serogroups 
specific LPS (Cohen et al., 1991; Cohen et al., 1996). A rapid latex agglutination 
procedure, the Wellcolex Colour Shigella tests,  had been developed for Shigella 
grouping (Bouvet and Jeanjean, 1992). Colony blot immunoassays were also 
developed by researchers in detection of Shigella and EIEC from stool and water 
samples using IpaC specific monoclonal antibody (Szakal et al., 2001; Szakal et al., 
2003). Another EIA format is dot-EIA test. In this format, specific antigens or 
antibodies are immobilized on a membrane usually nitrocellulose and the reaction is 
observed by enzyme activities. In a previous study, an antigenic membrane protein of 
35 kDa molecular weight which is specific to IgA in sera of patients infected with 
Shigella spp. had been demonstrated (Kirnpal-Kaur, 2001). A dot-EIA test was 
developed using this protein. 
 
There are many factors that prevent the usage of immunoassay tests in routine 
laboratory diagnostic application. Two major factors that determine the efficacy of 
immunoassay tests is the efficiency of formation of the antigen-antibody complex 
and the ability to detect these complexes. The specificity of an immunoassay test is 
dependent on the reaction between antibody and antigen. The sensitivity and 
specificity of the assay depend mainly on the type of antigens used. The limitations 
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of EIA involve the specificity and affinity of the antibodies used, cross-reactivity, the 
specific activity of the enzyme and substrate employed and efficiency of detection of 
signal. Besides, the test needs well trained and experienced staff for interpretation of 
results. The test is relatively time consuming, labour-intensive and is temperature 
dependent. As for colony blot immunoassay, the sensitivity of this diagnostic 
approach is limited by the number of colonies chosen from individual specimens for 
the assay. Furthermore, mutations resulting in the loss of the virulence protein (such 
as IpaC and IpaD) expression could lead to a false negative immune assays (Szakal 
et al., 2003). 
 
1.3.3.2  DNA-based method 
Technology advances in molecular biology has been introduced that will allow the 
genetic detection and identification of some microbes. Unlike traditional culture 
techniques, these methods are based on the detection of the genetic material of the 
targeted bacteria. In earlier studies, the DNA-based methods developed for the 
diagnosis of Shigella spp. were more on DNA-hybridization techniques (Venkatesan 
et al., 1989; Echeverria et al., 1991; Sansonetti, 1991). 
 
Amplification technology brings new possibilities for rapid detection of specific 
pathogens in a sample, including viruses, slowly growing bacteria, fastidious or 
uncultivable bacteria, fungi and protozoa (Vaneechoutte and Van, 1997). Most 
researchers started to utilize PCR (Polymerase Chain Reaction), the most promising 
DNA-based technique for their studies in detection and identification of pathogenic 
microorganisms (Lukinmaa, 2004), evaluation of emerging novel infections, 
surveillance, early detection of bio-threat agents and profiling of antimicrobial 
resistance (Yang and Rothman, 2004).  Important advantages of PCR are speed, a 
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good detection limit, selectivity, specificity, sensitivity and great potential for 
automation. It relies on the in vitro amplification of a targeted DNA fragment by a 
million fold in less than 2 hours. Moreover, the technology provides information on 
the current infection status and is dependent of the host‟s immune competency.  
 
Several PCR protocols for detection of pathogenic microorganisms have been 
published (Bej et al., 1990; Lampel et al., 1990; Josephson et al., 1993; Monteiro et 
al., 2001). Numerous studies reported that PCR technique is relatively more sensitive 
and specific than the conventional culture technique and has the potential to be 
employed in routine diagnosis of dysentery in clinical centers as well as in 
epidemiologic studies (Islam et al., 1998; Dutta et al., 2001; Luo et al., 2002; Aranda 
et al., 2004; Thiem et al., 2004). Several PCR protocols for the detection of Shigella 
spp. in faeces (Frankel et al., 1989; Sethabutr et al., 1993; Houng et al., 1997), 
environmental waters samples (Theron et al., 2001; M. Du Preez et al., 2003) and 
food (Lampel et al., 1990; Villabo and Torres, 1998) have been published. The 
application of DNA technology to diagnose Shigella spp. is based on the 
identification of DNA segments of a 120 to 140 MDa virulent plasmid that is 
necessary for attachment and invasion of epithelial cells. Most of the protocols 
developed were directed towards the specific DNA fragments of the invasion locus 
(ial) or the genes encoding for the ipaH. The invasion-associated plasmid antigen, 
ipaH, has been described as the genes that are found in multiple copies on both the 
invasion plasmid and on the chromosome of both Shigella spp. and EIEC (Hartman 
et al., 1990). These protocols showed PCR cross reactions with (EIEC) since the 
primers used were designed to amplify the gene that shared by EIEC and Shigella 
spp. Differentiation cannot be done between Shigella spp. 
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A few studies reported the utilization of the immunomagnetic separation techniques 
to specifically isolate Shigella from faeces and subsequently identified by PCR 
(Islam and Lindberg, 1992; Luo et al., 2002; Peng et al., 2002). The PCR protocols 
targeted shiga toxin genes and conserved regions of the 16S rRNA in Shigella spp. 
Applications of ELISA method to detect PCR products from amplification of ipaH 
gene sequences in EIEC and Shigella in diarrhoeal stool samples also have been 
exploited. The technique developed allowed screening of larger number of specimens 
and avoided the use of mutagenic reagents in preparing agarose gel for 
electrophoresis (Sethabutr et al., 2000).  In Thailand, Gaudio and colleagues (1997) 
also utilized the ELISA-PCR for their study of shigellosis among dysentery patients 
and family contacts.  
Another PCR technique with incorporation of digoxigenin-11-dUTP was also 
reported to detect Shiga toxin and shiga-like toxin type I (Sht/SLT-I)-producing S. 
dysenteriae and E. coli (Jackson, 1991). Labeled PCR products were hybridized to 
specific gene sequences which immobilized on a nitrocellulose membrane and 
detected by a few enzymes and substrates.  Real-time PCR is a significant 
advancement in the era of PCR technology. It has the potential to provide a faster 
and more sensitive method for detection of microorganisms. In another study, real-
time-fluorescence-based PCR assays was reported able to detect shiga toxin producer 
genes from S. dysenteriae and Escherichia coli (Belanger et al., 2002). For the 
detection of Shigella spp. in environmental water, seminested PCR was developed 
which also target the ipaH gene shared by Shigella spp. and EIEC. The studies 
suggested enrichment step prior to PCR assay to minimize PCR inhibitors (Theron et 
al., 2001; M. Du Preez et al., 2003). 
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A multiplex PCR assay was then reported for the detection of Shigella spp. and 
diarrheagenic E. coli using pure cultures isolated from stool specimens (Aranda et 
al., 2004). Later, a multiplex PCR assay was designed for simultaneous detection of 
chromosomal and plasmid-encoded virulence genes (set1A, set1B and ipaH) in 
Shigella spp. (Thong et al., 2005). In an earlier study, a multiplex PCR assay based 
on the rfc and virulent plasmid genes capable of distinguishing the various Shigella 
serotypes and EIEC had been described. The rfc gene is the gene that encodes for O-
antigen polymerase that polymerizes the O-antigen subunit into lipopolysaccharide 
(LPS) chains (Houng et al., 1997).  
Molecular study for the detection, identification and differentiation between 
enteroinvasive Escherichia coli and Shigella spp. was done in United States (US) 
utilizing PCR-Restriction Fragment Length Polymorphism (RFLP) method 
(Kingombe et al., 2005). The detection, identification, and differentiation of Shigella 
spp. and EIEC were achieved by analyses of the PCR patterns and RFLP types. It 
combined a multiplex PCR for the amplification of two virulence genes, iuc (222 bp) 
and ipaH (629 bp), amplification of the ial gene (a 1,038-bp amplicon) located 
within a large plasmid and RFLP of the ial gene amplicons for the two organisms.  
Recently, a few studies had reported the development of various formats of DNA and 
oligonucleotides microarray techniques. It is applied to screen multiple microbial 
organisms in diagnostic assays (Wu et al., 2001; Cho and Tiedje, 2002).  In 2006, a 
DNA microarray assay based on the target genes wzx, wzy and wfa U (genes 
encoding glycosyltransferase) of Shigella spp. and pathogenic E. coli serotypes was 
developed in China. The limitation of the test is its inability to distinguish S. sonnei 
and S. flexneri 2a from other strains that share the same O antigen structure and 
corresponding O antigen gene cluster (Li et al., 2006). Later, the same format of 
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diagnostic test was developed targeting O serotype-specific
 
genes in all 34 distinct O 
antigen forms of Shigella,
 
including Shigella boydii types 1–18, Shigella dysenteriae 
types 1–13, Shigella flexneri types 1–5 and 6 and Shigella sonnei. The microarray 
developed is the first reported microarray assay for serotyping all O antigen forms of 
Shigella (Li et al., 2009). More systematic and meticulous assessment and 
development is needed in understanding the full potential of microarrays for 
diagnostic studies. Furthermore, such technology requires sophisticated instruments 
in preparing and producing results for example array plate can only be read by laser 
scanner. In addition, it needs well trained personnel in handling the equipment with 
special setup, thus limiting its broad application in common laboratories (Zhou, 
2003). 
 
 1.4 Rationale of the study 
Current laboratory diagnostic methods used in detection and identification of 
Shigella spp. relied on the relatively time consuming growth in culture media, 
followed by isolation, biochemical screening and serological identification. It takes 
approximately 2 to 5 days to produce results. Immediate identification of the 
pathogen in specimens is very critical to ensure proper clinical treatment, 
management of the patients, controlling the spreading of the disease and for 
epidemiological studies. Nevertheless, the sensitivity is relatively low because the 
suspected bacterial colonies might be missed during the isolation step due to the 
delay in sample transportation prior processing. Furthermore, this conventional 
method really needs labor intensive culture technique for isolation of Shigella spp.  
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As mentioned earlier, there are number of DNA-based tests and immunoassay tests 
that have been developed for the diagnosis of shigellosis. The immunoassay methods 
developed needs well trained and experienced staff for interpretation of results, 
relatively time consuming, labour-intensive, temperature dependent and solely 
depends on the reaction between antibody and antigen used. Meanwhile, the DNA 
microarrays were time consuming in several post-PCR steps for detection of the 
organisms such as the hybridization of the PCR products to the DNA arrays which 
requires ~ 16 hours and needs special laboratory setup with expensive equipments. 
 
Detection methods based on nucleic acid such as PCR have shown tremendous 
potential and have been increasingly exploited. However, limiting issues in using 
PCR assays in diagnostic laboratory is that it is technically demanding; would need 
skilled personnel, requires many pipetting steps to add PCR reagents therefore prone 
to give erroneous results and need cold-chain for transportation and storage. 
Moreover, the presence of PCR inhibitors in the complex samples such as faeces, 
food and culture media may inhibit the amplification of the target genes thus limiting 
the usefulness of the PCR technique in diagnosis. 
 
Previously reported PCR protocols targeted virulence plasmid and toxin genes in 
Shigella spp. Since mutations, instability and loss of the genes may occur; it is 
seemly not reliable to use the virulence or toxin genes for the detection of Shigella 
spp. especially from environmental samples. The plasmid is known to be unstable 
even after long storage in culture collections and can be easily lost after overnight 
culture under nonselective or competitive condition. Strains may lose plasmids that 
harbour the target genes therefore give false negative results (Lampel et al., 1990). In 
